NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Remeditix Ventures’

8 January 2014

AVG Ventures, Remeditex help cancer treatment company Bellicum to $34.4m Series B

AVG Ventures and Remeditex Ventures have increased their backing of Bellicum Pharmaceuticals to help it raise $34.4m for its Series B round.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014